Cardioplegia, CPD Cardioplegia, Blood Cardioplegia, Microplegia, Micro Cardioplegia, Myocardial Protection, Myocardial Protection Cardioplegia - Adenocaine and the Thermacor 1200 from Smisson-Cartledge Biomedical
Future Uses
Future Uses
Currently, the Adenocaine™ compound is only available through compounding pharmacies that have an appropriate license from Hibernation Therapeutics to formulate the patented compound. However, additional technologies and applications are constantly being developed. One of the goals of Hibernation Therapeutics is to provide cost effective, clinically beneficial solutions to the medical community based on the Adenocaine™ technology.
We are currently developing:
- Solutions to help ambulance and other first responders stabilize severly injured patients in pre-hospital and remote rural environments.
- Military applications for resuscitation and protection against multi-organ failure for the injured soldier.
- Applications of the Adenocaine™ technology for Transplants, Graft Protection, Reduction of Vasospasms, Neurological Prortection, blunting the inflammatory response and protection of vital organs other than the heart.
